Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Return on Capital Employed [ROCE] (2026)

Updated

Kardigan's Return on Capital Employed [ROCE] was -47.17% in Q3 2026, up 16.51 percentage points from the prior quarter.

Analysis

Kardigan (KARD) Return on Capital Employed [ROCE] (2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Kardigan came in at -106.40%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Kardigan 1.29 Bn -398.44 Mn - -47.17%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -47.17%
Jun 30, 2026 -56.06%
API Access

Kardigan Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KARD&period=max&api_key=YOUR_API_KEY